Oxford vaccine team wins £1.4m to develop jab against ‘super gonorrhoea’

  30 March 2021

The Oxford University institute behind the AstraZeneca Covid vaccine has been awarded $2 million (£1.4m) to develop a jab against the increasing threat of “super gonorrhoea”. 

Researchers at the Jenner Institute believe their vaccine, one of just a handful currently in development, will prevent infections from different strains of the sexually transmitted infection (STI), including the most powerful multi-drug resistant forms that are spreading around the world. 

Further reading: The Telegraph
Author(s): Anne Gulland
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!